We are live on ! Find out more
ASTH icon

Astrana Health

142 hedge funds and large institutions have $1.52B invested in Astrana Health in 2021 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 61 increasing their positions, 24 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

543% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 7

154% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 24

136% more capital invested

Capital invested by funds: $643M → $1.52B (+$876M)

43% more call options, than puts

Call options by funds: $10.7M | Put options by funds: $7.47M

35% more funds holding

Funds holding: 105142 (+37)

11.49% more ownership

Funds ownership: 18.65%30.14% (+11%)

Holders
142
Holders Change
+37
Holders Change %
+35.24%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
45
Increased
61
Reduced
24
Closed
7
Calls
$10.7M
Puts
$7.47M
Net Calls
+$3.23M
Net Calls Change
+$3.23M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$534M +$210M +2,466,670 +73%
Vanguard Group
2
Vanguard Group
Pennsylvania
$287M +$120M +1,410,547 +81%
State Street
3
State Street
Massachusetts
$108M +$36.7M +431,606 +57%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$57.5M +$14.5M +169,984 +37%
Invesco
5
Invesco
Georgia
$55.6M +$33.9M +398,965 +189%
Northern Trust
6
Northern Trust
Illinois
$38.8M +$4.68M +54,979 +15%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$32M +$9M +105,825 +43%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$31.3M +$12.6M +148,582 +76%
EAM
9
Eagle Asset Management
Florida
$25.9M +$24.2M +284,564 New
Principal Financial Group
10
Principal Financial Group
Iowa
$25.2M +$14.2M +167,453 +153%
Charles Schwab
11
Charles Schwab
California
$23.8M +$10.4M +121,757 +87%
Ameriprise
12
Ameriprise
Minnesota
$14.4M +$8.65M +101,752 +181%
Goldman Sachs
13
Goldman Sachs
New York
$13.1M +$4.68M +54,992 +62%
Voloridge Investment Management
14
Voloridge Investment Management
Florida
$12.2M +$11.3M +133,459 New
Morgan Stanley
15
Morgan Stanley
New York
$11.7M +$2.59M +30,440 +31%
N
16
Nuveen
North Carolina
$11.4M -$1.08M -12,753 -10%
ZIM
17
Zacks Investment Management
Illinois
$10.3M +$7.12M +83,727 +286%
US Bancorp
18
US Bancorp
Minnesota
$8.4M +$7.84M +92,167 +115,209%
GKIM
19
GW&K Investment Management
Massachusetts
$8.13M -$7.41M -87,114 -49%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$8.13M -$1.23M -14,483 -14%
Legal & General Group
21
Legal & General Group
United Kingdom
$8.04M +$4.79M +56,372 +177%
RhumbLine Advisers
22
RhumbLine Advisers
Massachusetts
$8.01M +$2.42M +28,401 +48%
OAM
23
Ophir Asset Management
Australia
$8M -$7.33M -86,151 -50%
Public Sector Pension Investment Board (PSP Investments)
24
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$6.92M +$4.17M +49,070 +182%
Deutsche Bank
25
Deutsche Bank
Germany
$6.36M +$37.1K +436 +0.6%

ASTH Hedge Fund Activity: Q3 2021 in Review

142 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q3 2021, worth a combined $1.52B — up 136% from $643M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new ASTH positions and 7 closed out — a net gain of 38 holders — while 61 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $210M. The largest seller was JP Morgan Chase, cutting an estimated $10.4M.

  • 142 institutional investors held Astrana Health (ASTH) as of Q3 2021, up from 105 in Q2 2021.
  • Funds reported $1.52B of Astrana Health stock for Q3 2021, up 136% quarter-over-quarter.
  • 45 funds opened new Astrana Health positions in Q3 2021 and 7 closed out, a net change of +38 holders.
  • The largest Astrana Health buyer in Q3 2021 was BlackRock, an estimated $210M added.
  • The largest Astrana Health seller in Q3 2021 was JP Morgan Chase, an estimated $10.4M sold.

Based on aggregated 13F filings for Q3 2021.